Drug
Naglazyme
Naglazyme: highest development phase Not Applicable, developed by BioMarin Pharmaceutical. 1 trial record tracked on RxWires.
- Highest phase
- Not Applicable
- Developer
- BioMarin Pharmaceutical
Trials
| Drug | Phase | Indication |
|---|---|---|
| Naglazyme® NCT02156674 | Not Applicable | Maroteaux-Lamy Syndrome |
Latest
No recent events.
Follow Naglazyme on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.